Halise Akca

Halise Akca

Auto-generated profile, based on publicly available information

Halise Akca

Department of Physiology, Faculty of Medicine, Pamukkale University, 20070, Denizli, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
EPEmine Polat
Emine Polat
NTNilden Tuygun
Nilden Tuygun
HAHalise Akca
Halise Akca
CKCan Demir Karacan
Can Demir Karacan

11 December 2015 in Eurasian Journal of Emergency Medicine
Verified
Journal Article
Open access
HAHalise Akca
Halise Akca
NTNilden Tuygun
Nilden Tuygun
EPEmine Polat
Emine Polat
CKCan Demir Karacan
Can Demir Karacan

23 June 2025 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
ITIşık Tekin
Işık Tekin
GGGulsah Gundogdu
Gulsah Gundogdu
OKOzgen Kilic-Erkek
Ozgen Kilic-Erkek
IBIpek Buber
Ipek Buber
HAHasan Akca
Hasan Akca
GMGülçin Mete
Gülçin Mete

15 April 2025 in Bratislava Medical Journal
Verified
Journal Article
Open access
PDF file
OKOzgen Kilic-Erkek
Ozgen Kilic-Erkek
GGGulsah Gundogdu
Gulsah Gundogdu
TATunahan Anber
Tunahan Anber
HAHasan Akca
Hasan Akca
YDYavuz Dodurga
Yavuz Dodurga
A. M. Abd El-AtyA. M. Abd El-Aty
A. M. Abd El-Aty
Background: This study aimed to investigate the effects of alternate-day fasting (ADF) on body weight (BW), fat distribution, and key molecular markers related to endoplasmic reticulum stress (ERS) and sterol regulatory element-binding protein-1(SREBP-1) in young (3-month-old) and middle-aged (16-month-old) rats. Methods: Thirty-two male Wistar rats were divided into four groups: Group1 (ad libitum(AL)-fed young rats), Group2 (ADF-young rats), Group3 (AL-fed middle-aged rats), and Group4 (ADF-middle-aged rats). ADF was implemented as a 24 h feeding period followed by 24 h of fasting for 28 days. Serum and liver samples were analyzed via ELISA for SREBP-1, protein kinase RNA-like ER kinase (PERK), activating transcription factor-6 (ATF6), and glucose-regulated protein 78 (GRP78) levels. Results: Compared with Group-1, Group-3 had significantly greater BW and retroperitoneal fat content (p = 0.001). ADF reduced BW in young rats (Group-2 vs. Group-1,p = 0.015) but not in middle-aged rats (Group-4 vs. Group-3,p = 0.073). ADF significantly reduced fat accumulation in middle-aged rats (Group-4 vs. Group-3 p = 0.001), although fat accumulation was greater in middle-aged rats than in young rats (p = 0.001). Serum and liver PERK,GRP78,ATF6, and SREBP-1 levels were significantly greater in AL-fed middle-aged rats (Group-3 vs. Group-1,p < 0.05), indicating that ERS and lipid dysregulation increase with age. ADF significantly reduced these markers in middle-aged rats (Group-4 vs. Group-3,p < 0.05), suggesting a protective effect. Additionally, ADF lowered serum and liver SREBP-1 levels in young rats (Group-2 vs. Group-1,p = 0.003), highlighting its role in lipid metabolism regulation. Conclusions: ADF appears to be a promising nonpharmacological approach for mitigating age-related metabolic and molecular disturbances. Further research is warranted to explore its long-term effects and translational potential in human aging. Graphical

1 January 2025 in Pamukkale Medical Journal
Verified
Journal Article
Open access
PDF file
DADavut Akın
Davut Akın
MÇMevlüt Çeri
Mevlüt Çeri
GGGülşah Gündoğdu
Gülşah Gündoğdu
MBMehmet Batmazoğlu
Mehmet Batmazoğlu
EBEvrim Bozkaya
Evrim Bozkaya
HAHasan Akça
Hasan Akça
Purpose:This study aims to compare serum fibroblast growth factor 23 (FGF23) levels and chronic kidney disease-mineral and bone disorder (CKD-MBD) parameters in patients undergoing home hemodialysis (HHD) and center hemodialysis (CHD). Materials and methods: A total of 42 patients over 18 years old who had been receiving dialysis treatment for at least six months were included in the study. The patients were divided into two groups: HHD (n=17) and CHD (n=25). Demographic data, dialysis duration, biochemical parameters (serum phosphorus, calcium, parathyroid hormone, albumin, hemoglobin, FGF23, etc.), and medication use were recorded. Serum FGF23 levels were measured using the ELISA method from blood samples taken before midweek HD sessions. Frequency distributions were expressed as percentages and compared using the chi-square test. Results: The Kt/V values were higher in the HHD group (2.4±0.1 vs. 1.6±0.1), while serum phosphorus levels were lower (4.1±1.1 vs. 5.0±1.2 mg/dL). Although FGF23 levels were lower in the HHD group, the difference was not statistically significant (383±423 vs. 441±480 pg/mL, p>0.05). Erythropoietin (Epo) usage was significantly lower in the HHD group (47% vs. 92%, p=0.001). Conclusion: HHD was associated with better phosphorus control and a reduced requirement for EPO compared to CHD. The lower FGF23 levels in HHD suggest that this modality may offer advantages in CKD-MBD, cardiovascular outcomes, and mortality. However, these findings need to be supported by prospective studies involving larger patient populations.